Skip to main content
IPAR logo

IPAR · Interparfums Inc

Track IPAR — free
$133.37 +2.60 (+1.99%) At close · Nov 13
Market Cap
$4.27B
Shares
32.03M
Volume · Nov 13 221.78K Avg daily vol (3M) 227.79K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$133.37 Open$131.60 Day$131.00–133.92 52W close$79.57–136.16 Avg vol 30d231K Short int1.9M · 6.0% of shares · 9.8d Short vol50% Last earningsNov 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 4

Up next

Feb 24, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 5
Earnings call
2026 sales outlook raised to approximately $1.49 billion

Interparfum moderately increased its 2026 sales outlook to approximately $1.49 billion from $1.48 billion while maintaining diluted EPS of $4.85; nine-month net income was $142 million, or $4.43 per diluted share.

5 source passages
For the full year, we expect gross margins to improve by about 150 basis points. For the full year, we expect gross margins to improve by about 150 basis points. With 110 of these improvements coming from the tariff refunds and the balance coming from favorable brand channel mix, as well as cost efficiency programs, helping to offset the overall higher tariffs. Interparfum's consolidated results include two business segments, European-based operations through Interparfum SA, the company's 74% owned French subsidiary, and United States-based operations. In the first nine months, net income rose to $142 million. Or $4.43 per diluted share, compared to $140 million, or $4.36 per diluted share in the prior year period. As outlined in our earnings release issued last evening, despite the weakening euro, we are moderately increasing our sales outlook in 2026 from $1.48 billion to approximately $1.49 billion and maintaining diluted EPS of $4.85. Open the document at this passage
Nov 4
Current report 8-K
Interparfums raises 2026 sales guidance, reports flat Q3 sales

Interparfums reported third-quarter net sales of $430 million, raised 2026 sales guidance from $1.48 billion to $1.49 billion and maintained EPS of $4.85; nine-month sales were $1.1 billion.

Financial results, Regulation FD disclosure, Other events
4 source passages
INTERPARFUMS, INC. REPORTS 2026 THIRD QUARTER AND NINE-MONTH RESULTS; RAISES FULL YEAR SALES GUIDANCE AND REAFFIRMS EARNINGS OUTLOOK Third Quarter Net Sales of $430 Million with Diluted EPS of $2.13; Nine-Month Sales Increased to $1.1 Billion with Diluted EPS of $4.43 Consolidated sales growth in the third quarter was flat on a reported and organic basis. The Company is increasing its 2026 sales outlook from $1.48 billion to $1.49 billion and maintaining EPS of $4.85. Open the document at this passage
Nov 4
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $429.51M ▲ unchanged Net income $68.2M ▲ 3.6% Diluted EPS $2.13 ▲ 3.9%
Oct 20
Current report 8-K
Financial results, Regulation FD disclosure

Interparfums reported third-quarter net sales of $430 million, flat year over year. U.S. sales fell 7%, driven largely by supply chain disruptions that delayed giftsets representing approximately $10 million in sales, which will now be recognized in the fourth quarter.

Sep 22
Current report 8-K
Other events

Interparfums entered an exclusive, worldwide license agreement with PUMA to create, develop, produce and distribute fragrances under the PUMA brand through December 31, 2037, planning to introduce a signature lifestyle fragrance in 2027.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.50B
Trailing 12 months
Net income (TTM)
$170.15M
Trailing 12 months
Revenue growth YoY
0.0%
Year over year
Operating margin
17.9%
Trailing 12 months
P / E (TTM)
25.1
Trailing earnings · reciprocal yield 4.0%
FCF yield
5.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$12.76M
Latest balance sheet
Dividend yield
2.4%
Trailing 12 months
Shares change YoY
-0.3%
Year over year · fewer shares
Price change (1Y)
+52.5%
Trailing year
Short interest
6.0%
Latest settlement · 9.8 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Interparfums grew sales 2% in both the second quarter and first half, maintained 2026 guidance of $1.48 billion and $4.85 EPS, and delivered strong U.S.-based growth, broad regional and brand gains, improved cash conversion, and a sizable product-extension and blockbuster-launch pipeline. Operating margins declined amid higher marketing, tariff, royalty, and logistics costs; Lacoste remained weak, geopolitical and macroeconomic headwinds persist, and the second half is expected to decline, although the company authorized share repurchases, declared a dividend, and expects tariff refunds to improve full-year gross margin.

Bullish
  • + Sales grew 2% in both the second quarter and first half of 2026.
  • + Full-year guidance was maintained at $1.48 billion of sales and $4.85 EPS.
  • + U.S.-based operations posted strong sales growth and expanding margins.
  • + Growth was broad across major regions and brands, including North America, Asia-Pacific, Central and South America, Coach, GUESS, Ferragamo, and Donna Karan/DKNY.
  • + Cash conversion and inventory efficiency improved substantially, while tariff refunds are expected to improve full-year gross margin.
Bearish
  • − Marketing, royalty, tariff, and logistics costs increased, while SG&A and A&P rose as percentages of sales.
  • − European-based sales declined, with a 5% organic decline in both the quarter and first half.
  • − Lacoste sales declined 16% amid Eastern Europe challenges and difficult comparisons.
  • − Full-year guidance implies a 3% second-half sales decline, with approximately one point expected from adverse foreign exchange.
  • − The Middle East war, moderating international demand, economic concerns, tariffs, and supplier inflation remain risks.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +25%
above
Price vs 50-day avg +14%
above
RSI (14) 68
neutral
MACD trend Positive
52-week position 95%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +15%
trailing
6-month return +44%
trailing
YTD return +57%
this year
Relative strength +43%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $117 › 200d $106 — 50d above 200d
Institutional flow Accumulating
269 of 316 funds reported for Sep 30 · net +708.9K sh shares · +28 new
Insider flow Distributing
Net -$105.2K over 90 days · 100% sells
Short interest Falling
6.04% of shares out · ▼ -0.9% MoM · 9.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Squeeze score 78
high risk · 0–100
Fundamentals
Strong
Revenue growth +21%
Y/Y
Gross margin 72%
contracting
EPS growth +2%
Y/Y
Free cash flow $190.5M
Valuation P/E 25.1
in line
Balance sheet $17.9M
net debt
Quant / Vol
risk profile
Moderate
Volatility 32%
annualized · 1-yr
Max drawdown −17%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 5
Latest guidance · from the 8-K filed Oct 20, 2026
Sales · fourth quarter $10M
Previous outlook earlier release · from the Earnings Call filed Aug 5, 2026

Still-open targets the latest release did not restate under the same label.

Sales · full-year 2026 $1.48B
Guided vs delivered · last 5 settled
Sales full-year 2025
guided $1.47B
$1.49B Beat +1.3%
Diluted earnings per share full-year 2025
guided $5.12
$5.24 Beat +2.3%
Net sales full year 2024
guided $1.45B
$1.45B Beat +0.2%
Earnings per diluted share full year 2024
guided $5.15
$5.12 Miss −0.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 3 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+25% Bullish
Price vs 50-day avg
+14% Bullish
RSI (14)
68 Neutral
MACD trend
Positive Bullish
52-week position
95% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $117 › 200d $106 — 50d above 200d
Institutional flow Accumulating
269 of 316 funds reported for Sep 30 · net +708.9K sh shares · +28 new
Insider flow Distributing
Net -$105.2K over 90 days · 100% sells
Short interest Falling
6.04% of shares out · ▼ -0.9% MoM · 9.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $80 Now $133 · 95% Range high $136
vs 200-day avg +25% vs 50-day avg +14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
A&P expenses as a percentage of sales 22.6% the second quarter of 2026 —
Advertising and promotional (A&P) expenses 129M the first half of 2026 —
Donna Karan/DKNY fragrance sales growth 28% the second quarter of 2026 filing —
Ferragamo fragrance sales growth 41% the second quarter of 2026 filing —
Gross margin as a % of net sales (European based operations) 67.4% the three months ended June 30, 2026 filing —
Gross margin as a % of net sales (United States based operations) 61.6% the three months ended June 30, 2026 filing —
GUESS fragrance sales growth 10% the second quarter of 2026 filing —
Inventory days on hand 269 June 30, 2026 —
Jimmy Choo sales growth 23% the second quarter of 2026 filing —
Operating cash flow $46M the first half of 2026 —
Organic growth, United States based operations 17% the three months ended June 30, 2026 filing —
Organic sales growth 4% the three months ended June 30, 2026 filing —
Organic sales growth excluding Middle East war headwinds 4% the second quarter of 2026 —
Promotion and advertising included in selling, general and administrative expenses $77.2M the three months ended June 30, 2026 filing —
Royalty expense as a percentage of net sales 9.1% the three months ended June 30, 2026 filing —
Royalty expense included in selling, general and administrative expenses $30.9M the three months ended June 30, 2026 filing —
Sales growth, United States based operations 18% the 2026 second quarter —
Selling, general and administrative expenses as a percent of net sales (European based operation 53.9% the three months ended June 30, 2026 filing —
Selling, general and administrative expenses as a percent of net sales (United States based oper 44.2% the three months ended June 30, 2026 filing —
Selling, general and administrative expenses as a percentage of net sales 51.2% the three months ended June 30, 2026 filing —
Tariff refunds received $8.7M the second quarter of 2026 —
Total inventory reduction versus prior year 12% June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Household & Personal Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IPAR
Interparfums Inc
this stock
$4.27B +57.2% +21.3% 25.1 6.0%
PG
PROCTER & GAMBLE Co
$393.56B +18.5% +3.3% 25.6 1.0%
UL
Unilever PLC
$142.57B +1.2% — — 0.3%
CL
Colgate Palmolive Co
$79.23B +26.1% +1.7% 38.9 2.3%
RBGLY
Reckitt Benckiser Group PLC
$47.99B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
321
% held
69.4%
Reported
269 of 316
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
327
View
Short & Settlement
Short Interest Falling
Shares short
1.9M
Days to cover
9.8d
Change
-18.0K sh
View
Short Volume
Short vol %
50%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
32.9K
Value
$3.8M
As of
Oct 14, 2026
View
Off-Exchange
Off-exchange %
38.4%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$105.2K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.3B
Net income (FY)
$168.4M
EPS diluted
$5.24
View
Buybacks
Authorized
shares 260.0K
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 4, 2026
This year
23

Interparfums reported third-quarter net sales of $430 million, raised 2026 sales guidance from $1.48 billion to $1.49 billion and maintained EPS of $4.85; nine-month sales were $1.1 billion.

View
Proposed Sales
Value
$105.2K
Shares
900
Filed
Aug 27, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
INTERPARFUMS, INC. REPORTS 2026 T…
Published
Nov 4, 2026
View

Performance

5D 20D 120D MTD YTD
IPAR -1.6% +15.3% +43.9% +14.6% +57.2%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -4.2% +16.4% +43.4% +14.8% +46.6%

Capital returns

Latest dividend
$0.80 / share · ex Sep 15, 2026
Declared · upcoming
$0.80 / share · ex Dec 15, 2026
Raised 6.7%
Paid (TTM)
$3.20 / share · 4 payouts
Dividend yield (TTM, derived)
2.40%
Full dividend history
Buyback program · as of Apr 30, 2025
Authorized
shares 260,000
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 822663 CUSIP 458334109 13F (30d) 260 filings 232 filers Visit website Investor relations